These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18634857)

  • 1. The role of the opioid receptor-like (ORL1) receptor in motor stimulatory and rewarding actions of buprenorphine and morphine.
    Marquez P; Borse J; Nguyen AT; Hamid A; Lutfy K
    Neuroscience; 2008 Aug; 155(3):597-602. PubMed ID: 18634857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine.
    Marquez P; Nguyen AT; Hamid A; Lutfy K
    Neuropharmacology; 2008 Mar; 54(3):564-8. PubMed ID: 18082848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice.
    Bebawy D; Marquez P; Samboul S; Parikh D; Hamid A; Lutfy K
    Biol Psychiatry; 2010 Aug; 68(3):223-30. PubMed ID: 20359694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopamine D1 receptor-dependent β-arrestin signaling complex potentially regulates morphine-induced psychomotor activation but not reward in mice.
    Urs NM; Daigle TL; Caron MG
    Neuropsychopharmacology; 2011 Feb; 36(3):551-8. PubMed ID: 20980993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward.
    Borgkvist A; Usiello A; Greengard P; Fisone G
    Neuropsychopharmacology; 2007 Sep; 32(9):1995-2003. PubMed ID: 17251906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of endogenous PACAP in motor stimulation and conditioned place preference induced by morphine in mice.
    Marquez P; Bebawy D; Lelièvre V; Coûté AC; Evans CJ; Waschek JA; Lutfy K
    Psychopharmacology (Berl); 2009 Jun; 204(3):457-63. PubMed ID: 19199096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses.
    Sakoori K; Murphy NP
    Neuropsychopharmacology; 2008 Mar; 33(4):877-91. PubMed ID: 17522627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonistic effect of buprenorphine in a nociceptin/OFQ receptor-triggered reporter gene assay.
    Wnendt S; Krüger T; Janocha E; Hildebrandt D; Englberger W
    Mol Pharmacol; 1999 Aug; 56(2):334-8. PubMed ID: 10419552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
    Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
    J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine.
    Ciccocioppo R; Angeletti S; Sanna PP; Weiss F; Massi M
    Eur J Pharmacol; 2000 Sep; 404(1-2):153-9. PubMed ID: 10980274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
    Mandyam CD; Thakker DR; Christensen JL; Standifer KM
    J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor.
    Bloms-Funke P; Gillen C; Schuettler AJ; Wnendt S
    Peptides; 2000 Jul; 21(7):1141-6. PubMed ID: 10998549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism.
    Koizumi M; Sakoori K; Midorikawa N; Murphy NP
    Br J Pharmacol; 2004 Sep; 143(1):53-62. PubMed ID: 15289286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
    Cordery SF; Taverner A; Ridzwan IE; Guy RH; Delgado-Charro MB; Husbands SM; Bailey CP
    Addict Biol; 2014 Jul; 19(4):575-86. PubMed ID: 23240906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation.
    Thakker DR; Standifer KM
    Brain Res Mol Brain Res; 2002 Sep; 105(1-2):38-46. PubMed ID: 12399106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of beta-endorphin in the acute motor stimulatory and rewarding actions of cocaine in mice.
    Marquez P; Baliram R; Dabaja I; Gajawada N; Lutfy K
    Psychopharmacology (Berl); 2008 Apr; 197(3):443-8. PubMed ID: 18176854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.
    Nguyen AT; Marquez P; Hamid A; Kieffer B; Friedman TC; Lutfy K
    Eur J Pharmacol; 2012 Jul; 686(1-3):50-4. PubMed ID: 22575525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of morphine-conditioned place preference is more vulnerable than naloxone-conditioned place aversion to disruption by nociceptin in mice.
    Sakoori K; Murphy NP
    Neurosci Lett; 2008 Oct; 443(2):108-12. PubMed ID: 18662746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
    Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
    Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mu opioid receptor is involved in buprenorphine-induced locomotor stimulation and conditioned place preference.
    Marquez P; Baliram R; Kieffer BL; Lutfy K
    Neuropharmacology; 2007 May; 52(6):1336-41. PubMed ID: 17367825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.